Oscar Health, Inc.
NYSE:OSCR
16.99 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 5,862.869 | 4,125.584 | 1,920.961 | 589.641 | 553.779 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 5,862.869 | 4,125.584 | 1,920.961 | 589.641 | 553.779 |
| Gross Profit Ratio
| 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 339.716 | 309.783 | 265.078 | 166.655 | 110.682 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 |
| SG&A
| 339.716 | 309.783 | 265.078 | 166.655 | 110.682 |
| Other Expenses
| 5,758.768 | 4,243.722 | -2,763.099 | -1,163.16 | -924.925 |
| Operating Expenses
| 6,098.484 | 4,553.505 | -2,498.021 | -996.505 | -814.243 |
| Operating Income
| -235.615 | -584.175 | -577.06 | -406.864 | -260.464 |
| Operating Income Ratio
| -0.04 | -0.142 | -0.3 | -0.69 | -0.47 |
| Total Other Income Expenses Net
| -31.685 | -25.9 | 6.48 | 1.084 | 1.075 |
| Income Before Tax
| -267.3 | -610.075 | -570.58 | -405.78 | -259.389 |
| Income Before Tax Ratio
| -0.046 | -0.148 | -0.297 | -0.688 | -0.468 |
| Income Tax Expense
| 3.294 | -0.523 | 0.846 | 1.045 | 1.793 |
| Net Income
| -270.728 | -609.552 | -571.426 | -406.825 | -261.182 |
| Net Income Ratio
| -0.046 | -0.148 | -0.297 | -0.69 | -0.472 |
| EPS
| -1.22 | -2.87 | -3.19 | -1.7 | -1.09 |
| EPS Diluted
| -1.22 | -2.87 | -3.19 | -1.7 | -1.09 |
| EBITDA
| -235.615 | -568.892 | -562.455 | -395.579 | -253.565 |
| EBITDA Ratio
| -0.04 | -0.138 | -0.293 | -0.671 | -0.458 |